Ischemia Care Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Later Stage VC
  • (Cancelled)

  • Latest Deal Amount
  • $13M

  • Investors
  • 10

Ischemia Care General Information

Description

Developer of a blood testing and clinical decision support platform designed to improve diagnosis and care coordination in stroke and cardiovascular workflows. The company offers RNA (Ribonucleic Acid)-based diagnostics, a proprietary clinical dataset, and embedded decision support tools, enabling health systems and providers to reduce readmissions, lower care costs, and improve adherence to clinical guidelines.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 347 South College Avenue
  • Suite B
  • Oxford, OH 45056
  • United States
+1 (513)
Primary Industry
Diagnostic Equipment
Vertical(s)
Corporate Office
  • 347 South College Avenue
  • Suite B
  • Oxford, OH 45056
  • United States
+1 (513)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ischemia Care Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Later Stage VC $13M Cancelled Restart
12. Later Stage VC 01-Sep-2022 Completed Generating Revenue
11. Later Stage VC 15-May-2020 Completed Generating Revenue
10. Accelerator/Incubator 01-Jun-2019 Completed Generating Revenue
9. Later Stage VC 22-Dec-2017 Completed Generating Revenue
8. Later Stage VC 12-Oct-2016 Completed Product In Beta Test
7. Later Stage VC 25-Sep-2014 Completed Product In Beta Test
6. Later Stage VC (Series B3) 01-Jan-2014 Completed Product In Beta Test
5. Early Stage VC (Series B2) 01-Feb-2013 $330K $1.64M Completed Product In Beta Test
4. Early Stage VC (Series B) 01-Jul-2012 $810K $1.31M Completed Startup
To view Ischemia Care’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Ischemia Care Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a blood testing and clinical decision support platform designed to improve diagnosis and care coordination
Diagnostic Equipment
Oxford, OH
4 As of 2025

San Francisco, CA
 

Minneapolis, MN
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ischemia Care Competitors (10)

One of Ischemia Care’s 10 competitors is Viz.ai, a Venture Capital-Backed company based in San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Viz.ai Venture Capital-Backed San Francisco, CA
Medtronic Corporation Minneapolis, MN
Abbott Diagnostics Failed Transaction (M&A) Lake Forest, IL
RapidAI Venture Capital-Backed Golden, CO
Quanterix Formerly PE-Backed Billerica, MA
You’re viewing 5 of 10 competitors. Get the full list »

Ischemia Care Patents

Ischemia Care Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230332236-A1 Method for diagnosing stroke utilizing gene expression signatures Pending 08-Oct-2020
WO-2022076275-A1 Method for diagnosing stroke utilizing gene expression signatures Inactive 08-Oct-2020
US-12716097-B2 Biomarkers for the diagnosis of atrial fibrillation cause of stroke Active 13-Dec-2019
US-20230002829-A1 Biomarkers for the diagnosis of atrial fibrillation cause of stroke Active 13-Dec-2019
US-20260327704-A1 Biomarkers for the diagnosis of atrial fibrillation cause of stroke Pending 13-Dec-2019 C12Q1/6883
To view Ischemia Care’s complete patent history, request access »

Ischemia Care Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ischemia Care Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
John Lilly Strategic Insights Corporation Minority
Lateral Capital Management Venture Capital Minority
MedTech Innovator Accelerator/Incubator Minority
Solas BioVentures Venture Capital Minority
Broadview Ventures Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Ischemia Care FAQs

  • When was Ischemia Care founded?

    Ischemia Care was founded in 2009.

  • Where is Ischemia Care headquartered?

    Ischemia Care is headquartered in Oxford, OH.

  • What is the size of Ischemia Care?

    Ischemia Care has 4 total employees.

  • What industry is Ischemia Care in?

    Ischemia Care’s primary industry is Diagnostic Equipment.

  • Is Ischemia Care a private or public company?

    Ischemia Care is a Private company.

  • What is the current valuation of Ischemia Care?

    The current valuation of Ischemia Care is .

  • What is Ischemia Care’s current revenue?

    The current revenue for Ischemia Care is .

  • How much funding has Ischemia Care raised over time?

    Ischemia Care has raised $13.2M.

  • Who are Ischemia Care’s investors?

    John Lilly Strategic Insights, Lateral Capital Management, MedTech Innovator, Solas BioVentures, and Broadview Ventures are 5 of 10 investors who have invested in Ischemia Care.

  • Who are Ischemia Care’s competitors?

    Viz.ai, Medtronic, Abbott Diagnostics, RapidAI, and Quanterix are some of the 10 competitors of Ischemia Care.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process